GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Marketable Securities

Greenyn Biotechnology Co (ROCO:6846) Marketable Securities : NT$0.2 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Greenyn Biotechnology Co's Marketable Securities for the quarter that ended in Mar. 2024 was NT$0.2 Mil.

Greenyn Biotechnology Co's annual Marketable Securities declined from Dec. 2021 (NT$80.2 Mil) to Dec. 2022 (NT$0.2 Mil) but then stayed the same from Dec. 2022 (NT$0.2 Mil) to Dec. 2023 (NT$0.2 Mil).


Greenyn Biotechnology Co Marketable Securities Historical Data

The historical data trend for Greenyn Biotechnology Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Marketable Securities Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
0.15 0.15 80.17 0.15 0.15

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.15 0.15 0.15 0.15

Greenyn Biotechnology Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Greenyn Biotechnology Co  (ROCO:6846) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Greenyn Biotechnology Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines